Vincent DeVita

Vincent DeVita is an American oncologist and researcher who played a pivotal role in developing combination chemotherapy treatments that transformed cancer care. As Director of the National Cancer Institute from 1980 to 1988, he helped establish many of the protocols and practices still used in modern cancer treatment. His groundbreaking work in the 1960s and 70s led to the first successful cure for Hodgkin's lymphoma using a combination of four chemotherapy drugs, known as the MOPP regimen. This achievement marked one of the first times that an advanced cancer could be cured with drugs. DeVita has served as the President of the American Cancer Society and held prominent positions at Yale Cancer Center and Memorial Sloan Kettering Cancer Center. He is the author of several influential medical textbooks including "Cancer: Principles and Practice of Oncology," considered a definitive work in the field. His contributions to oncology have been recognized with numerous awards, including the Presidential Medal of Freedom and the American Medical Association's Scientific Achievement Award. DeVita continues to advocate for innovative approaches to cancer treatment and drug development through his writing and public speaking.

Readers consistently rate DeVita's most prominent book "The Death of Cancer" (co-written with Elizabeth DeVita-Raeburn) highly for its insider perspective on cancer treatment advances. Many readers appreciate his direct explanations of complex medical concepts and personal stories from his career. What readers liked: - Clear explanations of cancer treatment history and development - Behind-the-scenes look at medical research and drug approval processes - Personal accounts of working with patients - Balance of technical detail and accessible writing What readers disliked: - Some found sections about medical politics and bureaucracy too detailed - A few readers noted an occasionally self-congratulatory tone - Technical terminology can be challenging for non-medical readers Ratings: - Goodreads: 4.3/5 from 856 ratings - Amazon: 4.6/5 from 283 reviews Notable reader comment: "DeVita provides unique insight into how cancer treatment evolved, though sometimes gets bogged down in institutional politics." - Goodreads reviewer

The Death of Cancer: After Fifty Years on the Front Lines of Medicine (2015) A medical memoir covering DeVita's career in oncology research, the evolution of cancer treatment, and his personal experience with prostate cancer.

Hope-Fully: A Survivor's Guide to Cancer (2019) A guide detailing cancer treatment options, research developments, and practical advice for patients and families facing cancer diagnoses.

DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology (Multiple editions since 1982) A comprehensive medical textbook covering cancer biology, diagnostics, treatments, and clinical practices, widely used in oncology education and practice.

The Cancer Problem (1975) An examination of cancer research progress and challenges in the United States during the early years of the "war on cancer."

Siddhartha Mukherjee writes about cancer, medical history, and genetics from his perspective as an oncologist and researcher. His works like "The Emperor of All Maladies" combine patient stories with scientific developments in ways similar to DeVita's approach.

Jerome Groopman explores medical decision-making and doctor-patient relationships through case studies and research analysis. His focus on how doctors think and handle uncertainty mirrors DeVita's insights into clinical practice.

Atul Gawande examines healthcare systems, medical practice, and end-of-life care through personal experience as a surgeon. He addresses medical ethics and healthcare improvement in ways that complement DeVita's institutional critique.

Paul Kalanithi wrote about medicine from both doctor and patient perspectives after his diagnosis with terminal cancer. His work shares DeVita's interest in the dual nature of being both a provider and recipient of medical care.

Robert Weinberg focuses on cancer biology and the evolution of cancer research through firsthand experience. His writing combines technical expertise with historical context in the field of oncology, similar to DeVita's work.